Mindfulness app may soothe heartburn and anxiety in GERD patients

NCT ID NCT07667894

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an 8-week online mindfulness program can reduce emotional distress and reflux symptoms in 500 adults with gastroesophageal reflux disease (GERD). Participants are randomly assigned to either the mindfulness program or usual care. The goal is to see if learning to manage emotions can improve quality of life and reduce the burden of GERD.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
online mindfulness-based emotion intervention (MIED)
What this could lead to
If it works, this could offer a drug-free way to reduce stress and reflux symptoms for people with GERD.
What could go wrong
This is an early-stage trial with no prior results. The intervention is behavioral, so benefits may be modest and not replace standard medical care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMOTIONAL DISTRESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Houspital of Chifeng University

    Chifeng, Inner Mongolia, 024000, China

  • Baiyin Central Hospital

    Baiyin, Gansu, 730913, China

  • Being Haidian Hospital

    Beijing, Beijing Municipality, 100080, China

  • Center Hospital Qinghe County

    Xingtai, Hebei, 054899, China

  • Changzhi People'S Hospital

    Changzhi, Shanxi, 046000, China

  • PLA Rocket Force Characteristic Medical Center

    Beijing, Beijing Municipality, 100088, China

  • Peking University

    Beijing, Beijing Municipality, 100871, China

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, 518036, China

  • Shandong Second Provincial General Hospital

    Jinan, Shandong, 250022, China

  • Shanghai sixth people's hospital

    Shanghai, Shanghai Municipality, 200233, China

  • The First Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, 210029, China

  • Xilingol League Mongolian Medicine Hospital

    Hohhot, Inner Mongolia, 026000, China

  • Xinle City Hospital

    Xinle, Hebei, 050700, China

  • the Second People's Hospital of Liaocheng

    Liaocheng, Shandong, 252600, China

  • the first affiliated hospital of GuiZhou medical university

    Guiyang, Guizhou, 550004, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.